HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Histamine Dihydrochloride

HCID 5818
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
56-92-8
Standard SMILES
Cl.Cl.NCCc1cnc[nH]1
InChIKey
PPZMYIBUHIPZOS-UHFFFAOYSA-N
Molecular formula
C5H9N3.2ClH
Average molar mass
184.06 g/mol
Monoisotopic mass
183.0330028

Overview

Histamine Dihydrochloride is the hydrochloride salt form of histamine, with potential immunomodulatory and antineoplastic activities. Upon administration, histamine targets, binds to and activates histamine receptors. Depending on the amount of histamine administered and the type of receptor that is activated, histamine may exert a wide variety of activities. These can range from pro-tumorigenic to anti-tumor effects and may modulate the immune system to exert anti-tumor immune effects or may contribute to an inflammatory response.

Names & identifiers

Preferred name
Histamine Dihydrochloride
IUPAC
2-(1H-imidazol-5-yl)ethanamine;dihydrochloride
English name
Histamine dihydrochloride
Molecular formula
C5H11Cl2N3
Molecular weight
184.07

Names & synonyms

Histamine dihydrochloride56-92-8pereminCeplene1H-Imidazole-4-ethanamine, dihydrochloridehistaminum hydrochloricum3POA0Q644UROPANA Pain Relief CreamNSC-257873DTXSID10587671H-Imidazole-5-ethanamine, hydrochloride (1:2)Glucosamine Cream EXTRA STRENGTH
Show more names
HISTAMINE 2HCLHistaMine dihdrochlorideOCHLORIDEHistamine HCIHistaMine dihyHISTAMINE DIHCLhistaMine (HCl)2HistaMine Chloride
MaxamineHistamine 6XHistamine PhenolicNSC257873Histamine 1522RefChem:55301Pain Relieving ArthritisAustralian Dream Back Pain

Database identifiers

CAS
56-92-8
PubChem CID
5818
DTXSID
DTXSID1058767
ChEMBL
CHEMBL1533310

Properties

Computed structural properties

Topological polar surface area
54.7 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
10
Formal charge
0
Complexity
64.7

Experimental & physicochemical properties

Human DrugsEMA approved medicines: Human medicine
Collision Cross Section120.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
249 · 249-252 °C(lit.)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 0.1 g/mL, clear, colorless
form
powder
color
white to off-white
Water Solubility
SOLUBLE
Merck
14 · 14,4719
BRN
3624116 · 3624116
Stability
Stable. Incompatible with strong oxidizing agents.
InChI
InChI=1S/C5H9N3.2ClH/c6-2-1-5-3-7-4-8-5;;/h3-4H,1-2,6H2,(H,7,8);2*1H
InChIKey
PPZMYIBUHIPZOS-UHFFFAOYSA-N
SMILES
C1(N=CNC=1)CCN.Cl.Cl

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1% (1 of 98) of reports.

Danger

H315 (99%): Causes skin irritation [Warning Skin corrosion/irritation]

P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 98 reports by companies from 17 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 3 items

Chemical: 1H-Imidazole-5-ethanamine, hydrochloride (1:2)

REACH registered substance: 2-imidazol-4-ylethylamine dihydrochloride (EC: 200-298-4)

1H-Imidazole-4-ethanamine, dihydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesSkin Irrit. 2 (99%)

Safety data

F
1-8-9
wgk
2
tsca
TSCA listed
rtecs
MS1575000
ridadr
3335
hs_code
29332900
risk_code
36/37/38-42/43-42-22
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
Xn,Xi

Chemistry & industry

Pharmacology

ATC Code · 2 items

L - Antineoplastic and immunomodulating agents

QL - Antineoplastic and immunomodulating agents

MeSH Pharmacological ClassificationDrugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.

Uses & manufacturing

General Manufacturing Information1H-Imidazole-5-ethanamine, hydrochloride (1:2): ACTIVE
Applications · 4 items

UsesPresent in most mammalian tissues; primarily stored in mast cells and basophils. Exhibits multiple biological effects through at least 3 specific receptors. Induces bronchoconstriction and vasodilation; stimulates gastric acid secretion; and acts as a neurotransmitter.

UsesHistamine dihydrochloride has been shown to activate nitric oxide synthetase and suppress or inhibit the generation of reactive oxygen species (ROS). Inhibition of ROS by histamine dihydrochloride allows activation of T cells and NK cells by IL-2. In a rat model, histamine dihydrochloride suppressed ROS generated by Kupffer cells through the H2 histamine receptor. It is a potent vasodilator and endogenous histamine receptor agonist.

UsesHistamine dihydrochloride has been used:as a orthograde cotransmitter in producing excitatory postsynaptic potential (EPSP)to determine its level in fish using HPLC (high performance liquid chromatography)to assess the tracheal response to antigens in guinea-pigs

General DescriptionHistamine Dihydrochloride is a derivative of histamine, which is implicated in tumor cell apoptosis and prevents the relapse of acute myeloid leukemia in patients. It prevents the formation of ROS (reactive oxygen species) and inhibits the activation of T cells and natural killer cells.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
3POA0Q644U
EC Number
200-298-4
CAS DataBase Reference
56 · 56-92-8(CAS DataBase Reference)
FDA 21 CFR
310.545 · 310.545
NCI Dictionary of Cancer Terms
histamine dihydrochloride
FDA UNII
3 POA0Q644U · 3POA0Q644U
ATC code
3 AX14 · L03AX14
EPA Substance Registry System
1 H-Imidazole-4-ethanamine, · 1H-Imidazole-4-ethanamine, dihydrochloride (56-92-8)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
315 · H315-H317-H319-H334-H335
Precautionary statements
280 · P280-P302+P352-P305+P351+P338
Hazard Codes
Xn,Xi
Risk Statements
36 · 36/37/38-42/43-42-22
Safety Statements
22 · 22-26-36/37/39-45-37-36/37
RIDADR
3335 · 3335
WGK Germany
2 · 2
RTECS
1575000 · MS1575000
F
1 · 1-8-9
TSCA
TSCA listed
HazardClass
IRRITANT
HS Code
29332900 · 29332900
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 Resp · Eye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3
REACH Registrations
Active
safety_code
22-26-36/37/39-45-37-36/37
hazard_class
IRRITANT
Storage Class
11 - Combustible Solids
Hazard statements
H315-H317-H319-H334-H335
REACH Registrations
Active
Hazard Classifications
Eye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3
Precautionary statements
P280-P302+P352-P305+P351+P338

Suppliers100 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
山东雨禾医药科技有限公司15263077727 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
韶远科技(上海)有限公司4000665055 · [email protected]
科瑞迪化学400-821-5857 021-64326257 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
Syntechem Co.,Ltd[email protected]
Ark Pharm, Inc.847-367-3680 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
武汉凯威斯科技有限公司86-027-67849912 · [email protected]
安庆奇创药业有限公司18061456370 · [email protected]
上海瀚鸿科技股份有限公司021-54306202 13764082696 · [email protected]
上海相辉医药科技有限公司13761987713 · [email protected]
Pure Chemistry Scientific Inc.001-857-928-2050 or 1-888-588-9418 · [email protected]
上海瀚香生物科技有限公司177-54423994 17754423994 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
孝感深远化工有限公司15527621225; 15527621225 · [email protected]
山东西亚化学有限公司13355009207 13355009207 · [email protected]
玛雅试剂+86 (573) 82222445 (0)18006601000 452520369 · [email protected]
天津希恩思生化科技有限公司400 638 7771 · [email protected]
河南多贝化工有限公司0370-2785118 17550508557 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
艾科试剂4008-755-333 18080918076 · [email protected]
上海思域化工科技有限公司86-21-34053660 · [email protected]
赛默飞世尔科技(中国)有限公司800-810-5118 · [email protected]
北京伊诺凯科技有限公司400-810-7969 010-59572699 · [email protected]
Wuhan NCE Biomedical Co.,Ltd.4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
江苏艾康生物医药研发有限公司025-66113011 13913916777 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
上海贤鼎生物科技有限公司4009209199 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海永鸿实业集团化学科技有限公司86-21-50102722
越林试剂021-62960152 · [email protected]
上海睿升化工科技有限公司+86-021-50935922
南京杜莱生物技术有限公司025-84699383-8003;025-846993838003-8003 18013301590 · [email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
上海将来实业股份有限公司021-61552785 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]